Burosumab

ATC M05BX05 · 9 markets · 38 records

Burosumab 9 markets · 38 records Forms

AU 10 records · 7 strengths

  • 10 mginjectionCRYSVITA burosumab 10 mg/0.33 mL solution for injection in a 1 mL pre-filled syringeCRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial also in ES·US·TW unknown
  • 30 mginjectionCRYSVITA burosumab 10 mg/0.33 mL solution for injection in a 1 mL pre-filled syringeCRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial also in ES·US·TW unknown
  • 20 mginjectionCRYSVITA burosumab 10 mg/0.33 mL solution for injection in a 1 mL pre-filled syringeCRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial also in ES·US·TW unknown
  • 30 mg/1 mLinjectionCRYSVITA also in GB·ES
  • 20 mg/1 mLinjectionCRYSVITA also in GB·ES
  • 10 mg/1 mLinjectionCRYSVITA also in GB

Records without a stated strength · 1 CRYSVITA

GB 6 records · 5 strengths

ES 6 records · 5 strengths

US 3 records · 3 strengths

CA 3 records · 3 strengths

SG 3 records · 3 strengths

TW 3 records · 3 strengths

HK 3 records · 1 strengths

    Records without a stated strength · 1 CRYSVITA 10mg solution for injection

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 CRYSVITA

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.